Letrozole Cuts Risk Of Breast Cancer Recurrence Even After Tamoxifen Use
Recurrent Low-Grade Serous Carcinoma Less Responsive To Chemotherapy
BMI May Be Prognostic Tool For Types Of Breast Cancer
Postoperative Chemo Doesn’t Improve Survival, Study Finds
Risks Of Long-Term HRT Outweigh Benefits, WHI Finds
Cause Of Allergic Reaction To Cetuximab Found
NCI Cooperative Group, Cancer Center Trials Listed
Trending Stories
- Rachna Shroff, accomplished GI oncologist and “tireless mentor,” dies at 47
Her endowed award will live on - Oncologist Rachna Shroff endows award to outlast her cancer diagnosis
“Because of my health, I have a profound desire to see this endowment come to fruition now” - Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - VCU’s Baskin and UNC’s Ferris weigh oncology’s looming dilemma—MCDs
Center directors are strategizing for likely FDA approval of GRAIL’s Galleri - As FDA sidesteps the question of Galleri’s clinical benefit, NCI’s Letai has “some concerns”
- As trust in USPSTF erodes, cancer screening is in peril
David Ransohoff predicts a “Wild West” era without evidence-based screening guidelines









